GLOBAL ANKYLOSING SPONDYLITIS TREATMENT DRUG MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Nov 2021 103
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Ankylosing Spondylitis Treatment Drug
1.2 Classification of Ankylosing Spondylitis Treatment Drug by Type
1.2.1 Overview: Global Ankylosing Spondylitis Treatment Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Type in 2020
1.2.3 Non-steroidal Anti-inflammatory Drugs
1.2.4 Inhibitor
1.3 Global Ankylosing Spondylitis Treatment Drug Market by Sales Channel
1.3.1 Overview: Global Ankylosing Spondylitis Treatment Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Other
1.4 Global Ankylosing Spondylitis Treatment Drug Market Size & Forecast
1.5 Global Ankylosing Spondylitis Treatment Drug Market Size and Forecast by Region
1.5.1 Global Ankylosing Spondylitis Treatment Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Ankylosing Spondylitis Treatment Drug Market Size by Region, (2016-2021)
1.5.3 North America Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2016-2026)
1.5.6 South America Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Ankylosing Spondylitis Treatment Drug Market Drivers
1.6.2 Ankylosing Spondylitis Treatment Drug Market Restraints
1.6.3 Ankylosing Spondylitis Treatment Drug Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Ankylosing Spondylitis Treatment Drug Product and Solutions
2.1.4 Abbott Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Ankylosing Spondylitis Treatment Drug Product and Solutions
2.2.4 Merck Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Eisai
2.3.1 Eisai Details
2.3.2 Eisai Major Business
2.3.3 Eisai Ankylosing Spondylitis Treatment Drug Product and Solutions
2.3.4 Eisai Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eisai Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Ankylosing Spondylitis Treatment Drug Product and Solutions
2.4.4 Novartis Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Ankylosing Spondylitis Treatment Drug Product and Solutions
2.5.4 Pfizer Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Johson & Johson
2.6.1 Johson & Johson Details
2.6.2 Johson & Johson Major Business
2.6.3 Johson & Johson Ankylosing Spondylitis Treatment Drug Product and Solutions
2.6.4 Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Johson & Johson Recent Developments and Future Plans
2.7 Abbive
2.7.1 Abbive Details
2.7.2 Abbive Major Business
2.7.3 Abbive Ankylosing Spondylitis Treatment Drug Product and Solutions
2.7.4 Abbive Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Abbive Recent Developments and Future Plans
2.8 UCB
2.8.1 UCB Details
2.8.2 UCB Major Business
2.8.3 UCB Ankylosing Spondylitis Treatment Drug Product and Solutions
2.8.4 UCB Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 UCB Recent Developments and Future Plans
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Ankylosing Spondylitis Treatment Drug Product and Solutions
2.9.4 Amgen Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Amgen Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Ankylosing Spondylitis Treatment Drug Product and Solutions
2.10.4 Takeda Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Takeda Recent Developments and Future Plans
2.11 Mitsubishi Tanabe
2.11.1 Mitsubishi Tanabe Details
2.11.2 Mitsubishi Tanabe Major Business
2.11.3 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product and Solutions
2.11.4 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Mitsubishi Tanabe Recent Developments and Future Plans
2.12 Hisun Pharm
2.12.1 Hisun Pharm Details
2.12.2 Hisun Pharm Major Business
2.12.3 Hisun Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
2.12.4 Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Hisun Pharm Recent Developments and Future Plans
2.13 Guojian Pharmaceutical
2.13.1 Guojian Pharmaceutical Details
2.13.2 Guojian Pharmaceutical Major Business
2.13.3 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product and Solutions
2.13.4 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Guojian Pharmaceutical Recent Developments and Future Plans
2.14 Bio-Thera Solutions
2.14.1 Bio-Thera Solutions Details
2.14.2 Bio-Thera Solutions Major Business
2.14.3 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product and Solutions
2.14.4 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Bio-Thera Solutions Recent Developments and Future Plans
2.15 Maibo Pharma
2.15.1 Maibo Pharma Details
2.15.2 Maibo Pharma Major Business
2.15.3 Maibo Pharma Ankylosing Spondylitis Treatment Drug Product and Solutions
2.15.4 Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Maibo Pharma Recent Developments and Future Plans
2.16 Celgen Pharm
2.16.1 Celgen Pharm Details
2.16.2 Celgen Pharm Major Business
2.16.3 Celgen Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
2.16.4 Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Celgen Pharm Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Ankylosing Spondylitis Treatment Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Ankylosing Spondylitis Treatment Drug Players Market Share
3.2.2 Top 10 Ankylosing Spondylitis Treatment Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Ankylosing Spondylitis Treatment Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Ankylosing Spondylitis Treatment Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Ankylosing Spondylitis Treatment Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Application (2016-2021)
5.2 Ankylosing Spondylitis Treatment Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2026)
6.2 North America Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2026)
6.3 North America Ankylosing Spondylitis Treatment Drug Market Size by Country
6.3.1 North America Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2026)
6.3.2 United States Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2026)
7.2 Europe Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2026)
7.3 Europe Ankylosing Spondylitis Treatment Drug Market Size by Country
7.3.1 Europe Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2026)
7.3.2 Germany Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
7.3.3 France Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size by Region
8.3.1 Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Region (2016-2026)
8.3.2 China Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
8.3.5 India Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2026)
9.2 South America Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2026)
9.3 South America Ankylosing Spondylitis Treatment Drug Market Size by Country
9.3.1 South America Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2026)
9.3.2 Brazil Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Country
10.3.1 Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2026)
10.3.2 Turkey Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Ankylosing Spondylitis Treatment Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Ankylosing Spondylitis Treatment Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Ankylosing Spondylitis Treatment Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Ankylosing Spondylitis Treatment Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 9. Abbott Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 13. Merck Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eisai Corporate Information, Head Office, and Major Competitors
Table 15. Eisai Major Business
Table 16. Eisai Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 17. Eisai Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 21. Novartis Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 25. Pfizer Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Johson & Johson Corporate Information, Head Office, and Major Competitors
Table 27. Johson & Johson Major Business
Table 28. Johson & Johson Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 29. Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Abbive Corporate Information, Head Office, and Major Competitors
Table 31. Abbive Major Business
Table 32. Abbive Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 33. Abbive Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. UCB Corporate Information, Head Office, and Major Competitors
Table 35. UCB Major Business
Table 36. UCB Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 37. UCB Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Amgen Corporate Information, Head Office, and Major Competitors
Table 39. Amgen Major Business
Table 40. Amgen Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 41. Amgen Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Takeda Corporate Information, Head Office, and Major Competitors
Table 43. Takeda Major Business
Table 44. Takeda Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 45. Takeda Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Mitsubishi Tanabe Corporate Information, Head Office, and Major Competitors
Table 47. Mitsubishi Tanabe Major Business
Table 48. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 49. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Hisun Pharm Corporate Information, Head Office, and Major Competitors
Table 51. Hisun Pharm Major Business
Table 52. Hisun Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 53. Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Guojian Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 55. Guojian Pharmaceutical Major Business
Table 56. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 57. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Bio-Thera Solutions Corporate Information, Head Office, and Major Competitors
Table 59. Bio-Thera Solutions Major Business
Table 60. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 61. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Maibo Pharma Corporate Information, Head Office, and Major Competitors
Table 63. Maibo Pharma Major Business
Table 64. Maibo Pharma Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 65. Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Celgen Pharm Corporate Information, Head Office, and Major Competitors
Table 67. Celgen Pharm Major Business
Table 68. Celgen Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
Table 69. Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Ankylosing Spondylitis Treatment Drug Revenue (USD Million) by Players (2019-2021)
Table 71. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Players (2019-2021)
Table 72. Breakdown of Ankylosing Spondylitis Treatment Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Ankylosing Spondylitis Treatment Drug Players Head Office, Products and Services Provided
Table 74. Ankylosing Spondylitis Treatment Drug Mergers & Acquisitions in the Past Five Years
Table 75. Ankylosing Spondylitis Treatment Drug New Entrants and Expansion Plans
Table 76. Global Ankylosing Spondylitis Treatment Drug Revenue (USD Million) by Type (2016-2021)
Table 77. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Type (2016-2021)
Table 78. Global Ankylosing Spondylitis Treatment Drug Revenue Forecast by Type (2021-2026)
Table 79. Global Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021)
Table 80. Global Ankylosing Spondylitis Treatment Drug Revenue Forecast by Application (2021-2026)
Table 81. North America Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Ankylosing Spondylitis Treatment Drug Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Ankylosing Spondylitis Treatment Drug Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Ankylosing Spondylitis Treatment Drug Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Ankylosing Spondylitis Treatment Drug Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Ankylosing Spondylitis Treatment Drug Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Ankylosing Spondylitis Treatment Drug Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Ankylosing Spondylitis Treatment Drug Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Ankylosing Spondylitis Treatment Drug Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Ankylosing Spondylitis Treatment Drug Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Ankylosing Spondylitis Treatment Drug Picture
Figure 2. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Type in 2020
Figure 3. Non-steroidal Anti-inflammatory Drugs
Figure 4. Inhibitor
Figure 5. Ankylosing Spondylitis Treatment Drug Revenue Market Share by Sales Channel in 2020
Figure 6. Hospital Pharmacy Picture
Figure 7. Retail Pharmacy Picture
Figure 8. Online Pharmacy Picture
Figure 9. Other Picture
Figure 10. Global Ankylosing Spondylitis Treatment Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Ankylosing Spondylitis Treatment Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region (2016-2026)
Figure 13. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region in 2020
Figure 14. North America Ankylosing Spondylitis Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Ankylosing Spondylitis Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Ankylosing Spondylitis Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Ankylosing Spondylitis Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Ankylosing Spondylitis Treatment Drug Market Drivers
Figure 20. Ankylosing Spondylitis Treatment Drug Market Restraints
Figure 21. Ankylosing Spondylitis Treatment Drug Market Trends
Figure 22. Abbott Recent Developments and Future Plans
Figure 23. Merck Recent Developments and Future Plans
Figure 24. Eisai Recent Developments and Future Plans
Figure 25. Novartis Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Johson & Johson Recent Developments and Future Plans
Figure 28. Abbive Recent Developments and Future Plans
Figure 29. UCB Recent Developments and Future Plans
Figure 30. Amgen Recent Developments and Future Plans
Figure 31. Takeda Recent Developments and Future Plans
Figure 32. Mitsubishi Tanabe Recent Developments and Future Plans
Figure 33. Hisun Pharm Recent Developments and Future Plans
Figure 34. Guojian Pharmaceutical Recent Developments and Future Plans
Figure 35. Bio-Thera Solutions Recent Developments and Future Plans
Figure 36. Maibo Pharma Recent Developments and Future Plans
Figure 37. Celgen Pharm Recent Developments and Future Plans
Figure 38. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Players in 2020
Figure 39. Ankylosing Spondylitis Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Ankylosing Spondylitis Treatment Drug Revenue Market Share in 2020
Figure 41. Global Top 10 Players Ankylosing Spondylitis Treatment Drug Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Type in 2020
Figure 44. Global Ankylosing Spondylitis Treatment Drug Market Share Forecast by Type (2021-2026)
Figure 45. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Application in 2020
Figure 46. Global Ankylosing Spondylitis Treatment Drug Market Share Forecast by Application (2021-2026)
Figure 47. North America Ankylosing Spondylitis Treatment Drug Sales Market Share by Type (2016-2026)
Figure 48. North America Ankylosing Spondylitis Treatment Drug Sales Market Share by Application (2016-2026)
Figure 49. North America Ankylosing Spondylitis Treatment Drug Revenue Market Share by Country (2016-2026)
Figure 50. United States Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Ankylosing Spondylitis Treatment Drug Sales Market Share by Type (2016-2026)
Figure 54. Europe Ankylosing Spondylitis Treatment Drug Sales Market Share by Application (2016-2026)
Figure 55. Europe Ankylosing Spondylitis Treatment Drug Revenue Market Share by Country (2016-2026)
Figure 56. Germany Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Ankylosing Spondylitis Treatment Drug Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Ankylosing Spondylitis Treatment Drug Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region (2016-2026)
Figure 64. China Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Ankylosing Spondylitis Treatment Drug Sales Market Share by Type (2016-2026)
Figure 71. South America Ankylosing Spondylitis Treatment Drug Sales Market Share by Application (2016-2026)
Figure 72. South America Ankylosing Spondylitis Treatment Drug Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Ankylosing Spondylitis Treatment Drug Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Ankylosing Spondylitis Treatment Drug Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Ankylosing Spondylitis Treatment Drug Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source

Table of Contents

Related reports :

(Nov 21)

The Next-Generation Sequencing (NGS) Kits market report provides a detailed analysis of global market size, regional and country-level marke...

(Nov 21)

The Blood Pressure Maintenance Supplements market report provides a detailed analysis of global market size, regional and country-level mark...

(Nov 21)

The Mometasone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market...

(Nov 21)

The Fatty Acid Oxidation Disorder market report provides a detailed analysis of global market size, regional and country-level market size, ...

(Nov 21)

The RNase Control market report provides a detailed analysis of global market size, regional and country-level market size, segmentation mar...

(Nov 21)

The Bile Acid Sequestrant market report provides a detailed analysis of global market size, regional and country-level market size, segmenta...

Global Info Research

GLOBAL ANKYLOSING SPONDYLITIS TREATMENT DRUG MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy